Trailblazing MS doctor William Sheremata dies just after drug’s FDA approval
…
Press Release: Genentech’s OCREVUS (ocrelizumab) for people with relapsing or primary progressive forms of multiple sclerosis (MS)
…
Stuart Schlossman
RESERVE (RSVP) Seating for Unique Multiple Sclerosis Spanish event in Los Angeles, Ca
…
Stuart Schlossman
Ocrevus Seen in Phase 3 Trials to Benefit Both Primary Progressive and Relapsing MS Patients
…
Stuart Schlossman
Information for PPMS patients who would like access to OCREVUS /// Information on OCREVUS clinical trials for RMS patients
…
Stuart Schlossman
FDA EXTENDS REVIEW OF APPLICATION FOR OCREVUS™ (OCRELIZUMAB)
…
Stuart Schlossman
Updated information on Progressive MS
…
Stuart Schlossman
Dr. Daniel Kantor and Dr. Edward Fox discussing the use of Biotin for progressing forms of MS.
…
Stuart Schlossman
Primary Progressive Multiple Sclerosis (PPMS)
…
Stuart Schlossman
The Genentech Medical Affairs team is trying to recruit PPMS patients and their support partners for an advisory board this fall (2016)
…
Stuart Schlossman
